GSK UK - Imigran
Imigran is a market leader in migraine solutions and is available in both tablet and injection formats. It is a mature product which, prior to our outreach, has been given no marketing or sales support for five years.
- Injectable migraine treatment
- £6m annual sales
- No promotion since 2004
- Off patent in 2011
- GPs main prescriber
- No market access issues
- 9% decline forecasted due to generic launch in 2011
High impact creative supported by integrated Haymarket print and digital campaign. Extremely focused €37k advertising spend, tailored to product's needs + key advantages.
We've reminded GPs about a brand that they forgot.
Head of Mature Brands and Retail Trading Strategy – GSK
We're very pleased, it's a very good outcome – thanks Haymarket!
GSK Director and Head of European Procurement